KIRKLAND, Wash.--(BUSINESS WIRE)--Signostics, the global innovator in smart, high reliability ultrasound devices for urology, announced today that it has received U.S. Food and Drug Administration ...
Product launch enables new multi-function, vascular access and bladder measurement platform designed to improve patient care, HCAHPS results, and save nursing time SEATTLE--(BUSINESS WIRE)--EchoNous, ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Uscan (Signostics), the first smart mobile-connected ultrasound device for use in urologic care, according to a company news ...
SEATTLE, Sept. 28, 2017 (GLOBE NEWSWIRE) -- EchoNous, the parent company of Signostics, today announced a new $35 million dollar investment from KKR, a leading global investment firm. Building on ...
SEATTLE, Sept. 28, 2017 (GLOBE NEWSWIRE) — EchoNous, the parent company of Signostics, today announced a new $35 million dollar investment from KKR, a leading global investment firm. Building on KKR’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈